Figure 4From: Xenoantigen, an αGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell lineComplement dependent cytotoxic cross-match test NK7-transfected SUSM-1 cells (A) were resistant, while NK7-transfected MIA cells (D) were susceptible, to complement-mediated cell lysis. Dead cells appeared darker than living cells. Naïve SUSM-1 and naïve MIA cells showed similar results as that of NK7-transfected SUSM-1 cells.Back to article page